SEARCH

SEARCH BY CITATION

References

  • 1
    Beahrs OH, Shapiro S, Smart CR: Report of the working group to review the National Cancer Institute-American Cancer Society Breast Cancer Detection Demonstration Projects. J Natl Cancer Inst 1979; 62: 641709.
  • 2
    Baker LH: Breast Cancer Detection Demonstration Project: Five year summary report. CA Cancer J Clin 1982; 32: 196229.
  • 3
    Shapiro S, Venet W, Strax P, et al: Periodic Screening for Breast Cancer: The Health Insurance Plan Project and Its Sequelae, 1963–1986. Baltimore, The Johns Hopkins University Press, 1988.
  • 4
    Sickles EA: Mammographic features of malignancy found during screening. Recent Results Cancer Res 1990; 119: 8893.
  • 5
    Smart CR, Hartmann WH, Beahrs OH, et al: Insights into breast cancer screening of younger women: Evidence from the 14-year follow-up of the Breast Cancer Detection Demonstration Project. Cancer 1993; 72 (Suppl 4): 14491456.
  • 6
    Byrne C, Smart CR, Chu KC, et al: Survival advantage differences by age. Evaluation of the extended follow-up of the Breast Cancer Detection Demonstration Project. Cancer 1994; 74 (Suppl 1): 301310.
  • 7
    Smart CR: Highlights of the evidence of benefit for women 40–49 years from the 14-year follow-up of the Breast Cancer Detection Demonstration Project. Cancer 1994; 74 (Suppl 1): 296300.
  • 8
    Beahrs OH, Henson DE, Hutter RV, et al: Manual for Staging of Cancer, ed 4. Philadelphia, JB Lippincott, 1992, pp 1617.
  • 9
    Morrison AS, Brisson J, Khalid N: Breast cancer incidence and mortality in the Breast Cancer Detection Demonstration Project. J Natl Cancer Inst 1988; 80: 15401547.
  • 10
    Seidman H, Gelb SK, Silverberg E, et al: Survival experience in the Breast Cancer Detection Demonstration Project. CA Cancer J Clin 1987; 37: 258290.
  • 11
    SEER Program: SEER public use data 1973–1993. Bethesda, MD: NCI Cancer Statistics Branch, 1996.
  • 12
    Thurfjell EL, Lindgren JA: Breast cancer survival rates with mammographic screening: Similar favorable survival rates for women younger and those older than 50 years. Radiology 1996; 201: 421426.
  • 13
    Eddy DM: Screening for breast cancer. Ann Intern Med 1989; 111: 389399.
  • 14
    Eddy DM, Hasselblad V, McGivney W, et al: The value of mammography screening in women under age 50 years. JAMA 1988; 259: 15121519.
  • 15
    Miller BA, Feuer EJ, Hankey BF: Recent incidence trends for breast cancer in women and the relevance of early detection: An update. CA Cancer J Clin 1993; 43: 2741.
  • 16
    NCI reports improvements in breast cancer death rate. Cancer Facts SEER Home Page, Internet 1996. Web page address as follows: http://wwwicic.nci.hih.gov/ncifact/FS6_25.htm
  • 17
    Tabar L, Fagerberg G, Chen HH, et al: Tumour development, histology and grade of breast cancers: Prognosis and progression. Int J Cancer 1996; 66: 413419.
  • 18
    Duffy SW, Chen HH, Tabar L, et al: Estimation of mean sojourn time in breast cancer screening using a Markov chain model of both entry to and exit from the preclinical detectable phase. Stat Med 1995; 14: 15311543.
  • 19
    Tabar L, Fagerberg G, Day NE, et al: The Swedish two-county trial of mammographic screening for breast cancer: Recent results on mortality and tumor characteristics. Pathol Biol (Paris) 1992; 39: 846
  • 20
    Tabar L, Fagerberg G, Day NE, et al: Breast cancer treatment and natural history: New insights from results of screening. Lancet 1992; 339: 412414.
  • 21
    Tabar L, Duffy SW, Krusemo UB: Detection method, tumour size and node metastases in breast cancers diagnosed during a trial of breast cancer screening. Eur J Cancer Clin Oncol 1987; 23: 959962.
  • 22
    Tabar L, Gad A, Holmberg L, et al: Significant reduction in advanced breast cancer: Results of the first seven years of mammography screening in Kopparberg, Sweden. Diagnostic Imaging in Clinical Medicine 1985; 54: 158164.